M-8891

N/A

Report date: 2024/01/02 20:03:52
NME

Base Information

Drug NameM-8891
Drug Alias NameM-8891
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMethionine aminopeptidase 2 inhibitors
TargetsMethionine aminopeptidase 2
Therapy Area/IndicationsSolid tumoursCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Serono
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEmd Serono Research & Development Institute IncMerck KGaA, Darmstadt, Germany
Active IndicationsN/A
Inactive IndicationsSolid tumoursCarcinoma, Renal Cell

Other Information

ATC CodeN/A
Related LinksN/A